Business Daily Media

Business Marketing

.

Eisai: Supplementary New Drug Applications for Anti-Epileptic Drug Fycompa as Monotherapy for Partial-Onset Seizures

  • Written by ACN Newswire - Press Releases

Eisai: Supplementary New Drug Applications for Anti-Epileptic Drug Fycompa as Monotherapy for Partial-Onset Seizures

TOKYO, Oct 16, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that the supplementary new drug applications for its in-house discovered and developed anti-epileptic drug (AED) Fycompa (generic name: perampanel) as monotherapy for partial-onset seizures and pediatric indication for partial onset seizures in patients with epilepsy 4 years

Read more //?#

Popular

What is SEO: A Beginner's Guide to Understanding the Basics of SEO

Search Engine Optimization (SEO) is a powerful tool for online businesses and entrepreneurs looking to increase their visibility on the web. It is a process of optimizing websites and web pages so that they rank higher in sear...

iCAR ASIA LAUNCHES FIRST VIRTUAL EXPO IN INDONESIA

Mobil123.com, the Number 1 Automotive Portal in Indonesia, is to hold the first ever Mobil123 DRIVE Virtual Expo 2020 from July 25 – 2 August 2020. Responding to the new normal the Mobil123 DRIVE Virtual Expo 2020 is an a...

Marketplacer Partners With True Woo To Create New Online Wellness Marketplace

Marketplacer, creator of the world’s leading ecommerce platform, today announced the completion of a new holistic marketplace for Australian wellness company, True Woo. The marketplace features a portfolio of products and ser...

Virtual Office
Tomorrow Business Growth